dexmedetomidine has been researched along with Diabetic Neuropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Li, C; Lin, Y; Wei, Y; Yao, G; Yu, H; Zhang, W; Zhang, Y | 1 |
| Bo, Z; Fang, Z; Kang, L; Yayi, H; Zhongyuan, X | 1 |
| Hou, X; Huang, Z; Liang, Y; Shuai, J; Xu, F; Xu, X; Zhang, C | 1 |
| Lin, B; Lu, Y; Zhong, J | 1 |
| Geng, J; Guo, XY; Li, M; Li, ZQ; Ma, D; Masters, J; Sun, YB; Wang, DX; Wang, SL; Yu, ZY | 1 |
| Brummett, CM; Lirk, P | 1 |
6 other study(ies) available for dexmedetomidine and Diabetic Neuropathies
| Article | Year |
|---|---|
Dexmedetomidine alleviates oxidative stress and mitochondrial dysfunction in diabetic peripheral neuropathy via the microRNA-34a/SIRT2/S1PR1 axis.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Dexmedetomidine; Diabetes Mellitus; Diabetic Neuropathies; MicroRNAs; Mitochondria; Oxidative Stress; Rats; Sirtuin 2; Sphingosine-1-Phosphate Receptors | 2023 |
Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Blotting, Western; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Interleukin-1beta; Male; Microscopy, Electron, Transmission; Neural Conduction; NLR Family, Pyrin Domain-Containing 3 Protein; Pain Threshold; Random Allocation; Rats, Sprague-Dawley; Receptors, Purinergic P2X4; Reproducibility of Results; Signal Transduction; Spine; Streptozocin; Sural Nerve; Time Factors | 2019 |
Dexmedetomidine exerts neuroprotective effects during high glucose-induced neural injury by inhibiting miR-125b.
Topics: Animals; Apoptosis; Dexmedetomidine; Diabetic Neuropathies; Glucose; MicroRNAs; Neurons; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Rats; Reactive Oxygen Species; Receptors, Calcitriol; Signal Transduction; Up-Regulation | 2020 |
The Therapeutic Effect of Dexmedetomidine on Rat Diabetic Neuropathy Pain and the Mechanism.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Cytokines; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glutamic Acid; Hyperalgesia; Inflammation; Interleukin-1beta; Male; Microglia; Pain Threshold; Rats, Sprague-Dawley; Spinal Cord; Tumor Necrosis Factor-alpha; Yohimbine | 2017 |
Dexmedetomidine enhances ropivacaine-induced sciatic nerve injury in diabetic rats.
Topics: Adjuvants, Anesthesia; Anesthetics, Local; Animals; Cytokines; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Synergism; Inflammation Mediators; Male; Nerve Block; Neural Conduction; Peripheral Nerve Injuries; Rats, Sprague-Dawley; Ropivacaine; Sciatic Nerve | 2019 |
Regional anaesthesia, diabetic neuropathy, and dexmedetomidine: a neurotoxic combination?
Topics: Anesthesia, Conduction; Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Rats; Ropivacaine; Sciatic Nerve | 2019 |